Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Urticaria, Vaccination site erythema, Vaccination site induration, Vaccination site pruritus
Clinical narrative: She didn't get a 2nd Moderna Covid-19 Vaccine on the advice of her physician; Indurated at the site of injection; Itching at the site of vaccination; Armpit is really sore; Lymph node swelling in that arm; Half dollar-sized red area on her arm/ at site of injection; Hives on upper torso; Itchiness on my upper torso; Achiness; Asthma cough/ Cough; Nasal congestion; Itchy lip; Fatigue; Mild headache; This spontaneous case was reported by a physician and describes the occurrence of COUGH VARIANT ASTHMA (Asthma cough/ Cough), NASAL CONGESTION (Nasal congestion), LIP PRURITUS (Itchy lip), URTICARIA (Hives on upper torso) and PRURITUS (Itchiness on my upper torso) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced COUGH VARIANT ASTHMA (Asthma cough/ Cough), NASAL CONGESTION (Nasal congestion), LIP PRURITUS (Itchy lip), PRURITUS (Itchiness on my upper torso), PAIN (Achiness), FATIGUE (Fatigue) and HEADACHE (Mild headache). On 10-Mar-2021, the patient experienced URTICARIA (Hives on upper torso), VACCINATION SITE INDURATION (Indurated at the site of injection), AXILLARY PAIN (Armpit is really sore), LYMPHADENOPATHY (Lymph node swelling in that arm) and VACCINATION SITE ERYTHEMA (Half dollar-sized red area on her arm/ at site of injection). 10-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the site of vaccination). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (She didn't get a 2nd Moderna Covid-19 Vaccine on the advice of her physician). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 04-Mar-2021 to 05-Mar-2021 for Nasal congestion, at a dose of 25 milligram and ALBUTEROL [SALBUTAMOL] on 04-Mar-2021 for Asthma, at an unspecified dose and frequency. On 04-Mar-2021, COUGH VARIANT ASTHMA (Asthma cough/ Cough), NASAL CONGESTION (Nasal congestion), LIP PRURITUS (Itchy lip) and PRURITUS (Itchiness on my upper torso) had resolved. At the time of the report, URTICARIA (Hives on upper torso), PAIN (Achiness), VACCINATION SITE INDURATION (Indurated at the site of injection), VACCINATION SITE PRURITUS (Itching at the site of vaccination), AXILLARY PAIN (Armpit is really sore), LYMPHADENOPATHY (Lymph node swelling in that arm), VACCINATION SITE ERYTHEMA (Half dollar-sized red area on her arm/ at site of injection), FATIGUE (Fatigue) and HEADACHE (Mild headache) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (She didn't get a 2nd Moderna Covid-19 Vaccine on the advice of her physician) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, Antibody test: some antibodies but (Inconclusive) Some antibodies but not a high enough level to provide adequate protection.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Reporter occupation, new events and lab test was added.